Clinical trials
Terminated trials in Russia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health | 2 |
| AVEO Pharmaceuticals, Inc. | 1 |
| Alpha Tau Medical LTD. | 1 |
| Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife, Inc. | 1 |
| Efferon JSC | 1 |
| Karolinska Institutet | 1 |
| Medtronic Cardiac Rhythm and Heart Failure | 1 |
| Meshalkin Research Institute of Pathology of Circulation | 1 |
| Negovsky Reanimatology Research Institute | 1 |
| Novosibirsk Research Institute of Traumatology and Orthopaedics n.a. Ya.L. Tsivyan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 3 |
| Angina Pectoris | 1 |
| Breast Neoplasms | 1 |
| Bundle-Branch Block | 1 |
| Coronary Artery Disease | 1 |
| Disease | 1 |
| Heart Diseases | 1 |
| Heart Failure, Systolic | 1 |
| Hypotension | 1 |
| Leukemia, Myeloid, Acute | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.